AMGEN Inc.

NASDAQ:AMGN   3:59:59 PM EDT
251.39
+1.08 (+0.43%)
4:29:09 PM EDT: $251.38 -0.01 (-0.00%)
Other Pre-Announcement

Amgen Posts Qtrly Adjusted Earnings Per Share $3.70

Published: 04/27/2021 20:46 GMT
AMGEN Inc. (AMGN) - Amgen - Qtrly Total Revenues Decreased 4% to $5.9 Billion.
Amgen - Total Product Sales Decreased 5% for Q1 of 2021.
Amgen - 2021 Total Revenue Guidance Reaffirmed at $25.8 Billion -$26.6 Billion.
Q1 Earnings per Share View $4.05, Revenue View $6.25 Billion -- Refinitiv Ibes Data (analyst estimates).
Amgen - 2021 EPS Guidance Revised to $9.11- $10.71 on a GAAP Basis, and Reaffirmed at $16.00-$17.00 on a Non-GAAP Basis.
Amgen - Expect to See Continuing Disruption From Covid-19 in Q2 And, to a Lesser Degree, in H2 of Year.
Amgen - Sees FY 2021 Capital Expenditures to Be About $900 Million; Sees FY 2021 Share Repurchases in Range of $3.0 Billion to $5.0 Billion.
FY2021 Earnings per Share View $16.80, Revenue View $26.41 Billion -- Refinitiv Ibes Data (analyst estimates).
Amgen - Qtrly Earnings per Share $2.83; Qtrly Adjusted Earnings per Share $3.70.